Vitamin C recycling and function in human monocytic U-937 cells. 1999

J M May, and S Mendiratta, and Z C Qu, and E Loggins
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-6303, USA. james.may@mcmail.vanderbilt.edu

The uptake, recycling, and function of ascorbic acid was evaluated in cultured U-937 monocytic cells. Dehydroascorbic acid, the two-electron oxidized form of the vitamin, was taken up on the glucose transporter and reduced to ascorbate to a much greater extent than ascorbate itself was accumulated by the cells. In contrast to dehydroascorbic acid, ascorbate entered the cells on a sodium- and energy-dependent transporter. Intracellular ascorbate enhanced the transfer of electrons across the cell membrane to extracellular ferricyanide. Rates of ascorbate-dependent ferricyanide reduction were saturable, fivefold greater than basal rates, and facilitated by intracellular recycling of ascorbate. Whereas reduction of dehydroascorbic acid concentrations above 400 microM consumed reduced glutathione (GSH), even severe GSH depletion by 1-chloro-2,4-dinitrobenzene was without effect on the ability of the cells to reduce concentrations of dehydroascorbic acid likely to be in the physiologic range (< 200 microM). Dialyzed cytosolic fractions from U-937 cells reduced dehydroascorbic acid to ascorbate in an NADPH-dependent manner that appeared due to thioredoxin reductase. However, thioredoxin reductase did not account for the bulk of dehydroascorbic acid reduction, since its activity was also decreased by treatment of intact cells with 1-chloro-2,4-dinitrobenzene. Thus, U-937 cells loaded with dehydroascorbic acid accumulate ascorbate against a concentration gradient via a mechanism that is not dependent on GSH or NADPH, and this ascorbate can serve as the major source of electrons for transfer across the plasma membrane to extracellular ferricyanide.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D003683 Dehydroascorbic Acid The reversibly oxidized form of ascorbic acid. It is the lactone of 2,3-DIKETOGULONIC ACID and has antiscorbutic activity in man on oral ingestion. Acid, Dehydroascorbic
D004579 Electron Transport The process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. (From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270) Respiratory Chain,Chain, Respiratory,Chains, Respiratory,Respiratory Chains,Transport, Electron
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001205 Ascorbic Acid A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. Vitamin C,Ascorbic Acid, Monosodium Salt,Ferrous Ascorbate,Hybrin,L-Ascorbic Acid,Magnesium Ascorbate,Magnesium Ascorbicum,Magnesium di-L-Ascorbate,Magnorbin,Sodium Ascorbate,Acid, Ascorbic,Acid, L-Ascorbic,Ascorbate, Ferrous,Ascorbate, Magnesium,Ascorbate, Sodium,L Ascorbic Acid,Magnesium di L Ascorbate,di-L-Ascorbate, Magnesium
D013880 Thioredoxin-Disulfide Reductase A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXINS to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5 Thioredoxin Reductase (NADPH),NADP-Thioredoxin Reductase,NADPH-Thioredoxin Reductase,Thioredoxin Reductase,NADP Thioredoxin Reductase,NADPH Thioredoxin Reductase,Reductase, NADP-Thioredoxin,Reductase, NADPH-Thioredoxin,Reductase, Thioredoxin,Reductase, Thioredoxin-Disulfide,Thioredoxin Disulfide Reductase
D020298 U937 Cells A human cell line established from a diffuse histiocytic lymphoma (HISTIOCYTIC LYMPHOMA, DIFFUSE) and displaying many monocytic characteristics. It serves as an in vitro model for MONOCYTE and MACROPHAGE differentiation. Cell, U937,Cells, U937,U937 Cell

Related Publications

J M May, and S Mendiratta, and Z C Qu, and E Loggins
March 1995, Journal of medical microbiology,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
June 1997, Infection and immunity,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
September 2011, Journal of psychiatric research,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
April 2003, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
February 1990, Journal of cellular physiology,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
August 2008, Progress in neuro-psychopharmacology & biological psychiatry,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
September 1998, The American journal of physiology,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
June 1997, Biochemical pharmacology,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
July 1990, The American journal of physiology,
J M May, and S Mendiratta, and Z C Qu, and E Loggins
January 1990, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!